# Smooford International Ltd. · 66-41 · NIGERIA — FDA import alert red lists: firms subject to detention without physical examination For Smooford International Ltd. · 66-41 · NIGERIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is NIGERIA; product is To to Skin Soap; product code is 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 09/30/2009; address is Box 41 , Iperu-Remo , Ogun State, NIGERIA, verified against its source on 2026-09-16. - **Firm:** Smooford International Ltd. _(verified: appears in the quote below)_ - **Import alert:** 66-41 - **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S. - **Country:** NIGERIA _(verified: appears in the quote below)_ - **Address:** Box 41 , Iperu-Remo , Ogun State, NIGERIA _(verified: appears in the quote below)_ - **Date published:** 09/30/2009 _(verified: appears in the quote below)_ - **Product code:** 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: appears in the quote below)_ - **Product:** To to Skin Soap _(verified: appears in the quote below)_ - **FDA notes:** 7/2/2008 The labeling on this product makes several disease claims. On the “Indications/Claims” label, it states that the product should be used for ringworm, scabies and pediculosis capitis, which is a parasitic infection. Thus, this product is a drug under 201(g)(1), which is defined as “articles intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in man or other animals…” _(verified: appears in the quote below)_ ## What the source says > Smooford International Ltd. Date Published : 09/30/2009 Box 41 , Iperu-Remo , Ogun State, NIGERIA 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 02/05/2024 Desc: To to Skin Soap Notes: 7/2/2008 The labeling on this product makes several disease claims. On the “Indications/Claims” label, it states that the product should be used for ringworm, scabies and pediculosis capitis, which is a parasitic infection. Thus, this product is a drug under 201(g)(1), which is defined as “articles intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in man or other animals…” ## Source - https://www.accessdata.fda.gov/cms_ia/importalert_190.html Last verified: 2026-09-16. Review by: 2026-11-15. Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).